The latest announcement is out from Novavax (NVAX).
At the recent Annual Meeting, stockholders made significant decisions regarding the company’s governance and executive compensation. Directors were elected for a three-year term with a majority of votes cast in favor, and the advisory approval of the executive officers’ compensation for 2023 was also granted. Crucially, amendments to increase the number of shares available for the Stock Incentive and Employee Stock Purchase Plans were approved, expanding the potential for stock-based employee incentives. Additionally, the appointment of Ernst & Young LLP as the independent auditor for the upcoming fiscal year was ratified by an overwhelming majority.
For detailed information about NVAX stock, go to TipRanks’ Stock Analysis page.
